- |||||||||| midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
Trial completion date, Trial primary completion date: Evaluation of MDMA on Startle Response (clinicaltrials.gov) - Feb 19, 2020 P1, N=30, Recruiting, Active, not recruiting --> Completed Trial completion date: Dec 2019 --> Jul 2020 | Trial primary completion date: Nov 2019 --> Jul 2020
- |||||||||| midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
Trial completion date, Trial primary completion date: Evaluation of MDMA on Startle Response (clinicaltrials.gov) - Aug 14, 2019 P1, N=30, Recruiting, N=400 --> 150 Trial completion date: Aug 2019 --> Dec 2019 | Trial primary completion date: Jul 2019 --> Nov 2019
- |||||||||| midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
Trial completion date, Trial primary completion date: Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD (Canada) (clinicaltrials.gov) - Jul 23, 2019 P2, N=5, Active, not recruiting, Trial completion date: Aug 2019 --> Dec 2019 | Trial primary completion date: Jul 2019 --> Nov 2019 Trial completion date: Jul 2019 --> Oct 2019 | Trial primary completion date: Jun 2019 --> Sep 2019
- |||||||||| midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
Trial completion date, Trial primary completion date: A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1) (clinicaltrials.gov) - Jun 4, 2019 P3, N=100, Recruiting, Trial completion date: Jul 2019 --> Oct 2019 | Trial primary completion date: Jun 2019 --> Sep 2019 Trial completion date: Dec 2019 --> Jun 2020 | Trial primary completion date: Nov 2019 --> Jun 2020
- |||||||||| midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
Trial completion date, Trial primary completion date: Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD (clinicaltrials.gov) - Jan 14, 2019 P2, N=60, Recruiting, Trial completion date: May 2019 --> Aug 2019 | Trial primary completion date: Mar 2019 --> Jul 2019 Trial completion date: Jan 2019 --> May 2019 | Trial primary completion date: Dec 2018 --> Mar 2019
- |||||||||| midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
Trial completion date, Trial initiation date, Trial primary completion date: MDMA in Subjects With Moderate Hepatic Impairment and Subjects With Normal Hepatic Function (clinicaltrials.gov) - Dec 12, 2018 P1, N=16, Not yet recruiting, Trial completion date: Jan 2019 --> May 2019 | Trial primary completion date: Dec 2018 --> Mar 2019 Trial completion date: Sep 2019 --> Dec 2019 | Initiation date: Nov 2018 --> Mar 2019 | Trial primary completion date: Aug 2019 --> Nov 2019
- |||||||||| midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
Trial completion date, Trial primary completion date: Evaluation of MDMA on Startle Response (clinicaltrials.gov) - Dec 11, 2018 P1, N=30, Recruiting, Trial completion date: Sep 2019 --> Dec 2019 | Initiation date: Nov 2018 --> Mar 2019 | Trial primary completion date: Aug 2019 --> Nov 2019 Trial completion date: Jan 2019 --> Apr 2019 | Trial primary completion date: Nov 2018 --> Mar 2019
- |||||||||| midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
Enrollment open: A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1) (clinicaltrials.gov) - Nov 7, 2018 P3, N=100, Recruiting, Trial completion date: Dec 2018 --> Apr 2019 | Trial primary completion date: Oct 2018 --> Mar 2019 Not yet recruiting --> Recruiting
- |||||||||| midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
Trial completion date, Trial primary completion date: Evaluation of MDMA on Startle Response (clinicaltrials.gov) - Sep 13, 2018 P1, N=30, Recruiting, Trial completion date: Aug 2019 --> Dec 2019 Trial completion date: Sep 2018 --> Jan 2019 | Trial primary completion date: Aug 2018 --> Nov 2018
- |||||||||| midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
Trial primary completion date: MDMA-Assisted Psychotherapy for Anxiety Associated With a Life-Threatening Illness (clinicaltrials.gov) - Dec 8, 2017 P2, N=18, Active, not recruiting, Trial primary completion date: Jan 2018 --> May 2018 | Trial completion date: Mar 2018 --> Jul 2018 Trial primary completion date: Oct 2017 --> May 2018
- |||||||||| midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
Enrollment open: Evaluation of MDMA on Startle Response (clinicaltrials.gov) - Sep 25, 2017 P1, N=30, Recruiting, Recruiting --> Active, not recruiting | N=20 --> 12 | Trial primary completion date: Sep 2017 --> Jan 2018 Not yet recruiting --> Recruiting
- |||||||||| midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
New P1 trial: Evaluation of MDMA on Startle Response (clinicaltrials.gov) - Jun 8, 2017 P1, N=30, Not yet recruiting,
|